Biocompatibility and Pharmacokinetic Analysis of an Intracameral Polycaprolactone Drug Delivery Implant for Glaucoma
Investigative Ophthalmology & Visual Science2016Vol. 57(10), pp. 4341–4341
Citations Over TimeTop 10% of 2016 papers
Jean Kim, Max Kudisch, Sri Mudumba, Hiroyuki Asada, Eri Aya-Shibuya, Robert B. Bhisitkul, Tejal A. Desai
Abstract
Proof-of-concept PCL drug delivery devices containing DE-117 show promise as a long-term glaucoma treatment based on their zero-order drug release profile in vitro, biocompatibility in vivo, and effective distribution of released drug in relevant ocular tissues.
Related Papers
- → Biocompatibility of Hemodiafilters(2016)7 cited
- → Study on Polycaprolactone Coated Hierarchical Meso/ Macroporous Titania Scaffolds for Bone Tissue Engineering(2022)3 cited
- Preparation and biocompatibility research of modified PPC biomaterial(2007)
- Effect of Surface Properties on the Biocompatibility of Polyurethane(2007)
- Research on Structure Biocompatibility and Cell Biocompatibility of Silk Fibroin Scaffolds for Tissue Engineering(2013)